JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $43

BenzingaNov 25 09:22 ET · Ratings

TG Therapeutics Analyst Ratings

BenzingaNov 25 09:22 ET · Ratings

J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $43

Moomoo NewsNov 25 07:39 ET · Ratings

Express News | TG Therapeutics Inc : JP Morgan Raises Target Price to $43 From $30

ReutersNov 25 01:07 ET

A Closer Look at TG Therapeutics's Options Market Dynamics

BenzingaNov 21 12:18 ET

TG Therapeutics Ranked Number One on Deloitte Technology Fast 500 for Rapid Growth in Biopharmaceutical Sector

Quiver QuantitativeNov 21 06:11 ET